Skip to content
Loading…
Cheaper weight-loss drugs were expected to take off in India. But despite GLP-1s costing as little as $14 a month, demand has been slower than expected. From stigma to hesitant doctors, Satviki Sanjay explains why price isn’t the only barrier. (Source: Bloomberg)
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.